TESARO Inc. announced the achievement of development milestones that trigger an $18 million payment from Janssen Biotech Inc.
Cofactor Genomics has launched an RNA-based immune profiling kit developed for laboratories wishing to derive the immune composition of tumor samples.
Nearly four in 10 Americans believe cancer can be cured solely through alternative therapies, according to the American Society of Clinical Oncology's second annual National Cancer Opinion Survey.
Research in the October 2018 issue of JNCCN—Journal of the National Comprehensive Cancer Network--identifies risk factors for chemotherapy-induced febrile neutropenia.
The California Breast Cancer Research Program has launched the Global Challenge to Prevent Breast Cancer, a competition designed to surface game-changing research ideas to advance breast cancer prevention.
Barry Kramer, NCI's cancer prevention expert and an advocate for rigorous science announced his intention to retire from the institute.
Adam Margolin has been recruited by the Icahn School of Medicine at Mount Sinai to lead a new initiative to accelerate the pace of therapeutic discovery through integration of large-scale data analysis and advanced genomic technologies.
Andrzej Dlugosz was named associate director for basic science research at the University of Michigan Rogel Cancer Center.
Leonard Freedman was named chief science officer at the Frederick National Laboratory for Cancer Research.
Johnathan Whetstine was named program leader of the Cancer Epigenetics Program at Fox Chase Cancer Center.
